Testing effectiveness (Phase 2)Ended earlyNCT02318901
What this trial is testing
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
Who this might be right for
Advanced CancerBreast CancerGastric Cancer+2 more
Western Regional Medical Center 16